Trial
NCT04354025
Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
—
Condition
Refractory Acute Myeloid Leukemia
Intervention
Cytokine induced memory-like NK cells
Why stopped
Principal investigator decided not to move forward with the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-04